These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 26294105)

  • 1. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
    Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
    Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
    Wolsey DH; Larson SA; Creel D; Hoffman R
    J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit.
    Pilling RF; Lloyd IC; Huson S
    Eye (Lond); 2010 Oct; 24(10):1603-5. PubMed ID: 20689568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI.
    Saraç Ö; Alğin O; Beyazal M; Anlar FB; Varan A; Kansu AT
    Turk J Med Sci; 2019 Dec; 49(6):1626-1633. PubMed ID: 31655505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
    Listernick R; Ferner RE; Liu GT; Gutmann DH
    Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic pathway glioma of childhood.
    Rasool N; Odel JG; Kazim M
    Curr Opin Ophthalmol; 2017 May; 28(3):289-295. PubMed ID: 28257299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA; Bouffet E; Packer RJ; Reginald A
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant meningioma and glioma within the same optic nerve in neurofibromatosis type 1.
    Büyükkapu-Bay S; Akça A; Karadoğan M; Çorapçioğlu F; Anik Y
    J Child Neurol; 2014 Mar; 29(3):385-8. PubMed ID: 23420652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
    Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
    Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual loss in orbitofacial neurofibromatosis type 1.
    Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
    Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Strabismus Among Children With Neurofibromatosis Type 1 Disease With and Without Optic Pathway Glioma.
    Dotan G; Qureshi HM; Toledano-Alhadef H; Azem N; Yahalom C
    J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):19-22. PubMed ID: 30371910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of diffusion tensor tractography in pediatric optic pathway glioma.
    Lober RM; Guzman R; Cheshier SH; Fredrick DR; Edwards MS; Yeom KW
    J Neurosurg Pediatr; 2012 Oct; 10(4):273-80. PubMed ID: 22900485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
    Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG
    Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
    Avery RA; Mansoor A; Idrees R; Trimboli-Heidler C; Ishikawa H; Packer RJ; Linguraru MG
    Neurology; 2016 Dec; 87(23):2403-2407. PubMed ID: 27815398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.